Mexiletine in normal volunteers.
作者信息
Campbell N P, Kelly J G, Adgey A A, Shanks R G
出版信息
Br J Clin Pharmacol. 1978 Oct;6(4):372-3. doi: 10.1111/j.1365-2125.1978.tb00868.x.
Abstract
摘要
相似文献
1
Mexiletine in normal volunteers.美西律在正常志愿者中的应用。
Br J Clin Pharmacol. 1978 Oct;6(4):372-3. doi: 10.1111/j.1365-2125.1978.tb00868.x.
2
The clinical pharmacology of mexiletine.美西律的临床药理学。
Br J Clin Pharmacol. 1978 Aug;6(2):103-8. doi: 10.1111/j.1365-2125.1978.tb00833.x.
3
Dose independent pharmacokinetics of mexiletine in healthy volunteers.美西律在健康志愿者体内的非剂量依赖性药代动力学。
Br J Clin Pharmacol. 1986 Mar;21(3):319-21. doi: 10.1111/j.1365-2125.1986.tb05196.x.
4
Plasma mexiletine concentrations following combined oral and intramuscular administration.
Eur J Clin Pharmacol. 1981 Mar;19(4):301-4. doi: 10.1007/BF00562808.
5
Development of a dosage scheme for simultaneous intravenous and oral administration of mexiletine.
Postgrad Med J. 1977;53 Suppl 1:128-33.
6
[Kinetics of mexiletine distribution in the rat].
Arch Farmacol Toxicol. 1983 Apr;9(1):65-76.
7
New electron-capture gas-liquid chromatographic method for the determination of mexiletine plasma levels in man.
J Chromatogr. 1978 May 1;145(3):401-11. doi: 10.1016/s0378-4347(00)81369-9.
8
Adaptation of the dose of mexiletine according to pharmacokinetic data.
Acta Cardiol Suppl. 1980(25):67-73.
9
Pharmacokinetics of mexiletine in renal insufficiency.
Acta Cardiol Suppl. 1980(25):55-65.
10
Oral dosage schedules for mexiletine.
Postgrad Med J. 1977;53 Suppl 1:155-7.
引用本文的文献
1
Clinical pharmacokinetics of mexiletine.美西律的临床药代动力学。
Clin Pharmacokinet. 1999 Nov;37(5):361-84. doi: 10.2165/00003088-199937050-00002.
2
Plasma mexiletine concentrations following combined oral and intramuscular administration.
Eur J Clin Pharmacol. 1981 Mar;19(4):301-4. doi: 10.1007/BF00562808.
3
Absorption of mexiletine after treatment with gastric antacids.胃抗酸剂治疗后美西律的吸收情况。
Br J Clin Pharmacol. 1982 Nov;14(5):746-7. doi: 10.1111/j.1365-2125.1982.tb04969.x.
4
Pharmacokinetics of mexiletine in renal insufficiency.美西律在肾功能不全患者中的药代动力学。
Br J Clin Pharmacol. 1982 Sep;14(3):431-5. doi: 10.1111/j.1365-2125.1982.tb02003.x.
5
Enhanced metabolism of mexiletine after phenytoin administration.苯妥英钠给药后美西律代谢增强。
Br J Clin Pharmacol. 1982 Aug;14(2):219-23. doi: 10.1111/j.1365-2125.1982.tb01965.x.
6
Clinical pharmacokinetics of the newer antiarrhythmic agents.新型抗心律失常药物的临床药代动力学
Clin Pharmacokinet. 1984 Sep-Oct;9(5):375-403. doi: 10.2165/00003088-198409050-00001.
7
Stereoselective disposition of mexiletine in man.美西律在人体中的立体选择性分布。
Br J Clin Pharmacol. 1986 May;21(5):481-7. doi: 10.1111/j.1365-2125.1986.tb02829.x.
8
The metabolism of mexiletine in relation to the debrisoquine/sparteine-type polymorphism of drug oxidation.美西律的代谢与去甲异喹胍/鹰爪豆碱型药物氧化多态性的关系。
Br J Clin Pharmacol. 1991 Oct;32(4):459-66. doi: 10.1111/j.1365-2125.1991.tb03931.x.
本文引用的文献
1
Absorption, distribution and elimination of mexiletine.
Postgrad Med J. 1977;53 Suppl 1:50-5.
2
Measurement of plasma mexiletine concentrations.
Postgrad Med J. 1977;53 Suppl 1:48-9.
3
The clinical pharmacology of mexiletine.美西律的临床药理学。
Br J Clin Pharmacol. 1978 Aug;6(2):103-8. doi: 10.1111/j.1365-2125.1978.tb00833.x.
4
The development of mexiletine in the management of ventricular dysrhythmias.美西律在室性心律失常治疗中的发展。
Postgrad Med J. 1977;53 Suppl 1:114-9.
Zotero 插件